CLINICAL_TRIALS
trial_result
· 2016-03-10
Clinical Trial Update: Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea [Phase 3]
Summary
Phase 3 trial update on AGN-199201 for persistent erythema associated with rosacea reports efficacy and safety outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Erythema, Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2016-03-10